Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05053659
Title Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Brian Hill, MD, PhD

non-Hodgkin lymphoma

mantle cell lymphoma


Loncastuximab tesirine-lpyl + Venetoclax

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.